Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Genetics
Search: search_blue_button Advanced Search
Published Online
on September 14, 2009

Circulation: Cardiovascular Genetics. 2009
Published online before print September 14, 2009, doi: 10.1161/CIRCGENETICS.108.825547
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Winbo, A.
Right arrow Articles by Rydberg, A.
PubMed
Right arrow Articles by Winbo, A.
Right arrow Articles by Rydberg, A.
Related Collections
Right arrow Clinical genetics
Right arrow Arrhythmias, clinical electrophysiology, drugs

Original Article

Low Incidence of Sudden Cardiac Death in a Swedish Y111C-LQT1 Population

Annika Winbo1; Ulla-Britt Diamant; Eva–Lena Stattin; Steen M. Jensen and Annika Rydberg

Umeå University Hospital, Umeå, Sweden

* Corresponding author; email: annika.winbo{at}pediatri.umu.se

Background—A 10% cumulative incidence and a 0.3%/yr incidence rate of sudden cardiac death below 40 years of age and without therapy have been reported in the type 1 long QT syndrome. The Y111C-KCNQ1 mutation causes a severe phenotype in vitro, suggesting a high-risk mutation. Focusing on life-threatening cardiac events, this study investigates the phenotype among Y111C-KCNQ1 mutation-carriers in the Swedish population.

Methods and Results—We identified 80 mutation-carriers in 15 index families segregating the Y111C-KCNQ1 mutation during a national inventory of mutations causing the long QT syndrome. Twenty-four mutation-carriers <40 years of age experienced syncope (30%). One mutation-carrier had an aborted cardiac arrest (1.25%). No case of sudden cardiac death was reported during a mean non-medicated follow-up of 25±20 years. This corresponds to a low incidence rate of life-threatening cardiac events (0.05%/yr vs. 0.3%/yr, p=0.025). In 8 Y111C families connected by a common ancestor, the natural history of the mutation was assessed investigating the survival over the age of 40 for 107 non-medicated ascertained mutation-carriers (n=24) and family members (n=83) born between 1873 and 1968. In total, 4 deaths in individuals below the age of 40 were noted: one case of non-cardiac death and 3 infant deaths, between 1873 and 1915.

Conclusions—The dominant-negative Y111C-KCNQ1 mutation, associated with a severe phenotype in vitro, presents with a low incidence of life-threatening cardiac events in a Swedish population. This finding of discrepancy emphasizes the importance of clinical observations in the risk stratification of the long QT syndrome.

Key Words: death, sudden (if surviving, use heart arrest) • genetics • ion channels • long-QT syndrome • survival